BioNJ hosted Congresswoman Mikie Sherrill in a March 4 meeting about biotech in New Jersey at the facilities of Celularity.
Founded in 1994, BioNJ has worked to realize their “Patients Can’t Wait®,” mission by advocating for the life sciences industry in New Jersey and in Washington, as well as addressing issues and programs on both the state and federal levels. The meeting at Celularity, a clinical-stage biotechnology company developing placental-derived off-the-shelf allogeneic cell therapies, was aimed at furthering this mission by bringing industry and government together to discuss the growth and necessity of biotech.
During the meeting Dr. Robert Hariri, Chairperson, Founder and Chief Executive Officer of Celularity, gave the Congresswoman a tour of their facility. After which, Debbie Hart, the founding President and CEO of BioNJ, led a brief roundtable discussion on the biopharmaceutical industry.
This roundtable included Congresswoman Sherrill; Dr. Hariri, with Celularity; Florham Park Mayor Mark Taylor; Meghan Hunscher, President and CEO, Morris County Chamber of Commerce; Wendy Lazarus, Consultant/Vice President, Government Affairs, BioNJ; and Carlos Ramirez, Sr. Vice President, Investor Relations, Celularity.
